文献速递脑血管病

急性卒中随机临床试验中女性入组不足的荟萃分析

Sex Disparities in Enrollment in Recent Randomized Clinical Trials of Acute Stroke: A Meta-analysis.
PubMed 文献 · JAMA Neurol · 2021-01-01

该荟萃分析检索2010至2020年9大期刊的急性卒中治疗试验,将115项试验的女性入组比例与全球疾病负担数据库中女性卒中占比匹配。结果显示女性总体入组不足5.3个百分点,除蛛网膜下腔出血外各亚组均存在差异;设80岁年龄上限与女性入组减少6个百分点相关。

要点

  • 急性卒中试验中女性入组比例较 underlying 卒中人群低5.3个百分点
  • 该差异在地域、干预类型和卒中类型中普遍存在,蛛网膜下腔出血除外
  • 入组设80岁年龄上限与女性入组减少6个百分点相关,建议避免年龄上限

核心结论

  • 当代急性卒中随机临床试验中女性总体入组不足,除蛛网膜下腔出血外差异普遍存在。
  • 设置80岁年龄上限的入选标准与女性入组减少相关,应避免此类限制以最大化代表性。

研究设计与样本

  • 检索MEDLINE 2010年1月1日至2020年6月11日发表的急性卒中治疗试验。
  • 纳入报告2期或3期随机临床试验结果、患者为卒中或短暂性脑缺血发作、干预在发病1个月内启动的研究。
  • 由2名独立作者重复提取数据,将各试验与全球疾病负担数据库的女性卒中占比估计匹配。
  • 共检索到1529条结果,115项试验(7.5%)符合纳入标准。

主要发现

  • 随机效应汇总入组差异(EDD)为-0.053(95%CI,-0.065至-0.040),即女性入组不足5.3个百分点。
  • 该差异在地域、干预类型和卒中类型中几乎普遍存在,蛛网膜下腔出血除外(0.117[95%CI,0.084至0.150])。
  • 排除蛛网膜下腔出血试验后,汇总EDD为-0.067(95%CI,-0.078至-0.057)。
  • 多变量荟萃回归中,80岁年龄上限作为入选标准与女性入组减少6个百分点相关。

关键数值与推荐

  • 主要结局为入组差异(EDD),即试验参与者中女性比例与 underlying 疾病人群中女性卒中比例的绝对差。
  • 汇总EDD为-0.053(95%CI,-0.065至-0.040),提示女性入组不足5.3个百分点。
  • 蛛网膜下腔出血试验EDD为0.117(95%CI,0.084至0.150),排除后汇总EDD为-0.067(95%CI,-0.078至-0.057)。
  • 入选标准含80岁年龄上限与女性入组减少6个百分点相关。

临床怎么用

  • 解读急性卒中试验证据时需注意女性代表性不足可能影响结果外推。
  • 设计卒中试验时应避免设置年龄上限,以减少女性入组差异。
  • 针对女性卒中的治疗证据需结合入组差异谨慎评估。

局限性

  • 原文未报告具体局限性内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: The underenrollment of women in randomized clinical trials represents a threat to the validity of the evidence supporting clinical guidelines and potential disparities in access to novel treatments. OBJECTIVE: To determine whether women were underenrolled in contemporary randomized clinical trials of acute stroke therapies published in 9 major journals after accounting for their representation in underlying stroke populations. DATA SOURCES: MEDLINE was searched for acute stroke therapeutic trials published between January 1, 2010, and June 11, 2020. STUDY SELECTION: Eligible articles reported the results of a phase 2 or 3 randomized clinical trial that enrolled patients with stroke and/or transient ischemic attack and examined a therapeutic intervention initiated within 1 month of onset. DATA EXTRACTION: Data extraction was performed by 2 independent authors in duplicate. Individual trials were matched to estimates of the proportion of women in underlying stroke populations using the Global Burden of Disease database. MAIN OUTCOMES AND MEASURES: The primary outcome was the enrollment disparity difference (EDD), the absolute difference between the proportion of trial participants who were women and the proportion of strokes in the underlying disease populations that occurred in women. Random-effects meta-analyses of the EDD were performed, and multivariable metaregression was used to explore the associations of trial eligibility criteria with disparity estimates. RESULTS: The search returned 1529 results, and 115 trials (7.5%) met inclusion criteria. Of 121 105 randomized patients for whom sex was reported, 52 522 (43.4%) were women. The random-effects summary EDD was -0.053 (95% CI, -0.065 to -0.040), indicating that women were underenrolled by 5.3 percentage points. This disparity persisted across virtually all geographic regions, intervention types, and stroke types, apart from subarachnoid hemorrhage (0.117 [95% CI, 0.084 to 0.150]). When subarachnoid hemorrhage trials were excluded, the summary EDD was -0.067 (95% CI, -0.078 to -0.057). In the multivariable metaregression analysis, an upper age limit of 80 years as an eligibility criterion was associated with a 6-percentage point decrease in the enrollment of women. CONCLUSIONS AND RELEVANCE: Further research is needed to understand the causes of the underenrollment of women in acute stroke trials. However, to maximize representation, investigators should avoid imposing age limits on enrollment.

来源:JAMA Neurol,查看原文。版权归原作者所有。

引用

  1. Strong B, Pudar J, Thrift AG, et al. Sex Disparities in Enrollment in Recent Randomized Clinical Trials of Acute Stroke: A Meta-analysis. JAMA Neurol. 2021. PMID: 33900363. doi:10.1001/jamaneurol.2021.0873

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。